Trasis was founded in 2004 by Gauthier Philippart and Jean-Luc Morelle, the designers of the first radiosynthesizers to combine high-yield synthesis and GMP. They put together their expertise and their knowledge of the radiopharmaceutical industry and founded Trasis, an innovative and forward-looking company. Trasis has now a track-record in developing instruments and methods recognized throughout the world. At Trasis we are dedicated to helping the medical community access new radiolabelled therapeutic and diagnostic substances easily and faster. To this end, we
design, manufacture, sell and support high performance synthesizers, dose preparation equipment, their shielding and accessories. We also develop customized synthetic methods and instruments. We can provide GMP Active Pharmaceutical Ingredients (API)
and assist our customers with their regulatory affairs. Our proven radiopharmaceutical expertise, coupled with our high end instruments allow
us to provide fully integrated solutions for an effective tracer production and faster transition from drug development to marketing authorization.
Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies

www.trasis.com